Close Menu

NEW YORK — Centogene said on Wednesday that it has signed an agreement giving access to its rare disease data repository to Pfizer for use in the discovery of novel drug targets.

Centogene said the repository includes a range of rare disease patient data including clinical information, health records, and genetic, transcriptomic, proteomic, and metabolomic data. It also contains longitudinal data such as biomarkers or patient recorded outcomes, as well as diagnostic workflow data.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more. 

Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.